ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA clears Celltrion, Teva's biosimilar version of Roche's Herceptin
December 17, 2018Celltrion and Teva announced that the FDA has approved Herzuma (trastuzumab-pkrb), a biosimilar referencing Roche's Herceptin (trastuzumab), for the treatment of certain patients with HER2-overexpressing breast cancer. Specifically, Herzuma was cleared fo -
FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin
December 17, 2018Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Herzuma (trastuzumab-pkrb)..... -
Herceptin biosimilar Herzuma launched in Europe
May 07, 2018Mundipharma said its network of companies has kicked off the rollout of Celltrion’s Herceptin biosimilar Herzuma in Europe.
Pharma Sources Insight January 2025
